Implansense ingests transmissions from Abbott, Medtronic, and Biotronik remote monitoring platforms, classifies each episode, filters artifact, and ranks the results by clinical urgency — delivered as a sidebar view inside your existing Epic or Cerner workflow.
Six integrated modules handle the full ICM transmission workflow — from multi-manufacturer data ingestion through arrhythmia classification, artifact removal, clinical-context risk scoring, and EHR documentation. Each module addresses a distinct failure point in how EP clinics currently manage remote monitoring volume.
Implansense’s arrhythmia classification model processes raw telemetry waveforms from Abbott Confirm Rx, Medtronic LINQ II, and Biotronik BioMonitor transmissions. The model assigns multi-label classifications to each episode segment — covering atrial fibrillation burden percentage, R-R pause duration and count, ventricular tachycardia run length, supraventricular tachycardia episodes, and signal artifact. Each classification carries a confidence score derived from signal quality metrics, giving device coordinators an explicit indicator of episodes that warrant physician escalation versus routine review.
ICM transmissions frequently contain artifact from patient movement, lead sensing variability, and electromagnetic interference that the manufacturer platform flags identically to true arrhythmia events. Implansense runs a dedicated signal-quality scoring module on each episode segment prior to classification, applying morphology consistency analysis, R-wave amplitude stability checks, and frequency-domain noise metrics. Episodes scoring above the artifact threshold are tagged and sorted to the bottom of the coordinator worklist, reducing the volume of transmissions the coordinator must visually inspect before reaching clinically relevant events.
Two transmissions showing the same arrhythmia classification carry different clinical urgency depending on whether the patient was implanted for cryptogenic stroke workup, unexplained syncope evaluation, or AF burden quantification before an ablation decision. Implansense ingests the patient’s device indication from the EHR encounter, prior classified episodes from the last 90 days, and current anticoagulation status from the medication list to weight each new transmission against the patient’s specific risk profile. The risk stratifier produces a daily worklist sorted from urgent to routine, so coordinators work the highest-risk cases first without reading every transmission note.
After a device coordinator reviews a transmission in the Implansense worklist, the system generates a structured review summary formatted for addendum entry into Epic or Cerner. The summary includes episode date range, device model and implant date, classified arrhythmia findings with burden metrics, artifact exclusion note, and recommended action tier (physician review required, routine follow-up, no action). Coordinators can edit the summary before submitting. The export eliminates the manual dictation step that coordinators at pilot sites cited as the primary cause of documentation delay after transmission review.
Implansense generates a weekly alert fatigue report for the EP clinic showing true-positive arrhythmia rate, artifact rate, and coordinator review time per patient cohort, segmented by device model and device indication. Clinics can identify patients whose transmissions are predominantly artifact — often due to lead micro-dislodgement or patient behavior — and flag them for an in-clinic device check before the next scheduled follow-up. The report is exportable as a PDF for quality committee review and is automatically generated every Monday morning without coordinator action.
Implansense connects to Abbott Merlin.net, Medtronic CareLink Network, and Biotronik Home Monitoring Service via each manufacturer’s documented API or HL7 FHIR device observation interface. Clinics authenticate once per platform using their existing remote monitoring credentials; Implansense then ingests transmissions automatically as they arrive without requiring coordinators to log into each manufacturer portal separately. The multi-platform integration is the primary operational relief point for EP clinics managing mixed device inventories — a common situation in practices that implant both Abbott and Medtronic devices.
Implansense integrates with all three major ICM manufacturer remote monitoring platforms and the two most common EP clinic EHR systems. No proprietary data lock-in — transmissions and classifications remain accessible through your existing infrastructure.
We’ll walk through how Implansense handles Abbott, Medtronic, or Biotronik transmissions for a clinic your size. The demo takes 30 minutes and uses realistic EP clinic data rather than a scripted slideshow.